| Literature DB >> 29400021 |
An Jen Chiang1,2, Chung Chang3, Chi Hsiang Huang4, Wei Chun Huang5,6,7, Yuen Yee Kan8, Jiabin Chen9,10.
Abstract
OBJECTIVE: The objective was to identify risk factors that were associated with the progression from endometriosis to ovarian cancer based on medical insurance data.Entities:
Keywords: Cohort Studies; Endometriosis; Ovarian Neoplasms; Risk Factors
Mesh:
Year: 2018 PMID: 29400021 PMCID: PMC5920215 DOI: 10.3802/jgo.2018.29.e28
Source DB: PubMed Journal: J Gynecol Oncol ISSN: 2005-0380 Impact factor: 4.401
Characteristics of the cohort in study
| Variables (n=229,617) | Medium (range) | |
|---|---|---|
| Age (yr) | 41.07 (2.24–96.41) | |
| Time to ovarian cancer (day) | 2,438 (0–5,113) | |
| Post-endometriosis ovarian cancer (%) | 0.64 | |
| Hospital stratification (%) | ||
| Medical centers | 49.28 | |
| Regional hospitals | 37.32 | |
| District hospitals | 12.58 | |
| Local hospitals | 0.82 | |
| Urbanization (%) | ||
| Highly urbanized | 35.71 | |
| Moderately urbanized | 32.03 | |
| Newly urbanized | 15.40 | |
| Rural areas | 11.02 | |
| Others* | 5.84 | |
| Premium range (monthly income, NTD) | ||
| >15,840 and ≤25,000 | 15.56 | |
| ≤15,840 | 47.73 | |
| >25,000 | 36.71 | |
| Comorbidity | ||
| Myocardial infarction | 0.14 | |
| Congestive heart failure | 0.42 | |
| Peripheral vascular disease | 0.11 | |
| Cerebrovascular diseases | 1.18 | |
| Dementia | 0.05 | |
| Chronic pulmonary disease | 1.08 | |
| Rheumatologic disease | 0.45 | |
| Peptic ulcer disease | 2.02 | |
| Mild liver disease | 0.40 | |
| Diabetes | 2.76 | |
| Diabetes with chronic complications | 0.38 | |
| Hemiplegia/paraplegia | 0.17 | |
| Renal disease | 0.41 | |
| Moderate/severe liver disease | 0.15 | |
| AIDS | 0.00 | |
| Parkinson's disease | 0.09 | |
| Stroke | 1.18 | |
| Coronary heart disease | 1.21 | |
| Immune rheumatism | 0.45 | |
| Depression | 1.36 | |
| Hypertension | 5.22 | |
| Hyperlipidaemia | 1.53 | |
| Pelvic inflammation | 6.36 | |
| Childbearing post endometriosis | 9.65 | |
AIDS, acquired immune deficiency syndrome; NTD, New Taiwan Dollar.
*Others includes areas with aged population, agrarian towns and cities, and remote areas.
Significant factors in univariate analysis
| Variables | Hazard ratio | p | 95% confidence interval | |
|---|---|---|---|---|
| Age (yr) | 1.06 | <0.001 | 1.06–1.07 | |
| Hospital stratification | ||||
| Medical centers | Reference | |||
| Regional hospitals | 0.61 | <0.001 | 0.54–0.68 | |
| District hospitals | 0.46 | <0.001 | 0.54–0.56 | |
| Local hospitals | 0.19 | <0.001 | 0.06–0.58 | |
| Urbanization | ||||
| Highly urbanized | Reference | |||
| Moderately urbanized | 0.80 | <0.001 | 0.70–0.90 | |
| Newly urbanized | 0.72 | <0.001 | 0.61–0.85 | |
| Rural areas | 0.72 | <0.001 | 0.60–0.87 | |
| Others* | 0.81 | 0.070 | 0.64–1.02 | |
| Premium range (NTD/month) | ||||
| >15,840 and ≤25,000 | Reference | |||
| ≤15,840 | 1.25 | <0.001 | 1.08–1.44 | |
| >25,000 | 1.23 | <0.001 | 1.10–1.38 | |
| Comorbidity | ||||
| Congestive heart failure | 2.46 | <0.001 | 1.50–4.03 | |
| Cerebrovascular diseases | 1.79 | <0.001 | 1.27–2.52 | |
| Peptic ulcer disease | 1.83 | <0.001 | 1.41–2.38 | |
| Mild liver disease | 1.89 | 0.030 | 1.07–3.34 | |
| Diabetes | 1.99 | <0.001 | 1.60–2.47 | |
| Renal disease | 2.87 | <0.001 | 1.80–4.57 | |
| Stroke | 1.79 | <0.001 | 1.27–2.52 | |
| Depression | 1.86 | <0.001 | 1.35–2.56 | |
| Hypertension | 2.05 | <0.001 | 1.74–2.41 | |
| Pelvic inflammation | 1.85 | <0.001 | 1.58–2.17 | |
| Childbearing | 0.33 | <0.001 | 0.25–0.44 | |
NTD, New Taiwan Dollar.
*Others includes areas with aged population, agricultural towns and cities, and remote areas.
Independent risk factors in multivariate analysis
| Variables | Hazard ratio | p | 95% confidence interval | |
|---|---|---|---|---|
| Age (yr) | 1.06 | <0.001 | 1.06–1.07 | |
| Hospital stratification | ||||
| Medical centers | Reference | |||
| Regional hospitals | 0.64 | <0.001 | 0.57–0.72 | |
| District hospitals | 0.50 | <0.001 | 0.41–0.61 | |
| Local hospitals | 0.28 | 0.030 | 0.09–0.86 | |
| Urbanization | ||||
| Highly urbanized | Reference | |||
| Moderately urbanized | 0.85 | 0.010 | 0.75–0.96 | |
| Newly urbanized | 0.77 | <0.001 | 0.66–0.91 | |
| Rural areas | 0.79 | 0.010 | 0.65–0.95 | |
| Others* | 0.87 | 0.240 | 0.69–1.10 | |
| Premium range (NTD/month) | ||||
| >15,840 and ≤25,000 | Reference | |||
| ≤15,840 | 1.27 | <0.001 | 1.10–1.46 | |
| >25,000 | 1.23 | <0.001 | 1.10–1.38 | |
| Comorbidity | ||||
| Depression | 1.67 | <0.001 | 1.21–2.30 | |
| Pelvic inflammation | 2.73 | <0.001 | 2.32–3.22 | |
| Childbearing | 0.69 | 0.010 | 0.52–0.92 | |
NTD, New Taiwan Dollar.
*Others includes areas with aged population, agricultural towns and cities, and remote areas.
Fig. 1Nomogram of risk factors in the progression from endometriosis to ovarian cancer.
OC-free prob, ovarian cancer-free probability; NTD, New Taiwan Dollar.
The scales of the risk factors are as follows: *Age: continuous; †Hospital stratification: 1, medical center; 2, regional hospitals; 3, district hospitals; 4, local hospitals; ‡Premium range in NTD: 1, >15,840 and ≤25,000; 2, ≤15,840; 3, >25,000; §Depression: 0, none; 1, history of depression; ∥Pelvic inflammation: 0, none, 1, history of pelvic inflammation; ¶Childbearing: 0, none after endometriosis; 1, history of birth-giving after endometriosis.